Humana Inc.’s Stock Price Soars to $261.44, Marking a Robust 2.50% Increase

Humana Inc. (HUM)

261.44 USD +6.37 (+2.50%) Volume: 1.45M

Humana Inc.’s stock price is currently valued at 261.44 USD, showcasing a positive trading session with a percentage change of +2.50%. With a robust trading volume of 1.45M, the stock’s performance continues to thrive YTD, registering a percentage change of +3.05%. Invest in HUM for promising returns.

Latest developments on Humana Inc.

Humana Inc. (NYSE:HUM) has been making headlines recently with various developments impacting its stock price. Analysts have set a consensus target price of $285.68 for the company, while concerns have been raised about the impact of conservative accounting on its earnings. Despite this, Humana has been expanding its value-based oncology care through a new agreement with Thyme Care, attracting investments from firms like Fisher Funds Management LTD and Peregrine Asset Advisers Inc. Truist Financial Corp and Howard Capital Management Inc. have also increased their positions in the company, while others like Principal Financial Group Inc. have trimmed their stakes. With a new partnership in cancer care and positive upgrades from StockNews.com, Humana seems poised for growth in the near future.

Humana Inc. on Smartkarma

Analysts on Smartkarma are bullish on Humana Inc, a company that provides Medicare Advantage plans to around 6 million members. According to Value Investors Club, Humana focuses on promoting value-based care relationships with providers and incentivizing cost-saving behaviors to provide efficient and high-quality care. The research report published 3 months ago highlights the company’s efforts in preventative treatment and paying for outcomes rather than the volume of services provided.

Baptista Research suggests that Humana could be the next major acquisition target for Cigna, one of its rivals in the U.S. health insurance market. The report mentions that informal talks between Cigna and Humana have resumed after falling apart last year. This news comes at a time when Humana has been facing challenges due to changes in the government’s Medicare plan ratings, impacting its performance in the market.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has received positive Smart Scores across the board, indicating a strong outlook for the company in the long term. With high scores in Value and Dividend, investors can expect good returns and consistent payouts. The company’s Momentum score also suggests that it is performing well in the market, which bodes well for its future growth potential. While Growth and Resilience scores are slightly lower, the overall outlook for Humana Inc. remains optimistic based on the Smart Karma Smart Scores.

As a managed health care company, Humana Inc. provides coordinated health care to its members in the United States and Puerto Rico. Offering a range of health care plans and products to various customer groups, including employer groups and government-sponsored plans, Humana Inc. has established itself as a key player in the industry. With strong Smart Scores in key areas, the company is well-positioned for continued success and growth in the coming years.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma